tradingkey.logo
tradingkey.logo
Search

Nervgen Pharma Ord Shs

NGEN
Add to Watchlist
1.770USD
+0.095+5.67%
Close 07-23 16:00ETQuotes delayed by 15 min
140.98MMarket Cap
LossP/E TTM

NGEN Financials

See Nervgen Pharma Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Nervgen Pharma Ord Shs Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.02/-0.09
Revenue / Forecast
75.69K/0.00
Period
FY2025 Earnings
Revenue(YoY)
239.63K
--
EPS(YoY)
-0.44
-79.23%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
Financial Indicators
EPS
---0.02
---0.27
Revenue
--75.69K
--44.33K
Net Profit
---1.22M
---19.34M
Net Margin
---1610.07%
---43627.26%
Debt to assets ratio
--0.00%
--0.04%
Revenue
--75.69K
--44.33K
Operating profit
---5.48M
---4.60M
Net Profit
---1.22M
---19.34M
Current assets
--14.82M
--16.39M
Total current liabilities
--11.07M
--14.18M
Total assets
--15.10M
--16.68M
Total liabilities
--11.07M
--14.18M
Total equity
--4.03M
--2.50M
Net operating income
---5.96M
---4.60M
Net investment
--6.12K
--18.13K
Net financing
--2.02M
--12.03M

FAQs

What is the total revenue of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total revenue reached 239.63K, with a year-on-year change of 239.63K.

What are the current assets of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its current assets were 16.39M, with a year-on-year change of 21.48.

What are the total assets of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total assets of Nervgen Pharma Ord Shs were 16.68M, with a year-on-year change of 20.66.

What are the total liabilities of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total liabilities of Nervgen Pharma Ord Shs were 14.18M, with a year-on-year change of 18.21.

What is the total equity of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total equity of Nervgen Pharma Ord Shs was 2.50M, with a year-on-year change of 36.70.

What is the net operating income of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net operating income of Nervgen Pharma Ord Shs was -18.02M, with a year-on-year change of -1.90.

What is the net investment of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net investment of Nervgen Pharma Ord Shs was 72.54K, with a year-on-year change of 73.66.

What is the net financing of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net financing of Nervgen Pharma Ord Shs was 17.08M, with a year-on-year change of 6.07.

What is the Earnings Per Share (EPS) of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -0.44, with a year-on-year change of -79.23.

What is the net income of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net income was -31.71M, with a year-on-year change of -86.17.

What is the debt-to-asset ratio of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its debt-to-asset ratio was 0.04, with a year-on-year change of -93.35.

What is the Return on Equity (ROE) of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -1457.57, with a year-on-year change of 82.77.

What is the Return on Assets (ROA) of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -206.66, with a year-on-year change of -40.85.

What is the operating profit of Nervgen Pharma Ord Shs?

According to Nervgen Pharma Ord Shs's FY2025 earnings report, its operating profit was -18.02M, with a year-on-year change of -1.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.